Rank | Gene Set | Z-score |
---|---|---|
1 | exogenous drug catabolic process (GO:0042738) | 8.16428249 |
2 | epoxygenase P450 pathway (GO:0019373) | 7.93958683 |
3 | omega-hydroxylase P450 pathway (GO:0097267) | 7.79531010 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.62027981 |
5 | L-phenylalanine catabolic process (GO:0006559) | 7.62027981 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.29196705 |
7 | L-phenylalanine metabolic process (GO:0006558) | 7.29196705 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 6.82717965 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.46375828 |
10 | indole-containing compound catabolic process (GO:0042436) | 6.14424171 |
11 | indolalkylamine catabolic process (GO:0046218) | 6.14424171 |
12 | tryptophan catabolic process (GO:0006569) | 6.14424171 |
13 | kynurenine metabolic process (GO:0070189) | 6.03121161 |
14 | bile acid biosynthetic process (GO:0006699) | 5.97422853 |
15 | drug metabolic process (GO:0017144) | 5.84559505 |
16 | glyoxylate metabolic process (GO:0046487) | 5.83279975 |
17 | tryptophan metabolic process (GO:0006568) | 5.78726608 |
18 | negative regulation of fibrinolysis (GO:0051918) | 5.77543885 |
19 | urea metabolic process (GO:0019627) | 5.74187216 |
20 | urea cycle (GO:0000050) | 5.74187216 |
21 | oxidative demethylation (GO:0070989) | 5.73316964 |
22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.70730659 |
23 | alpha-linolenic acid metabolic process (GO:0036109) | 5.57741464 |
24 | phenylpropanoid metabolic process (GO:0009698) | 5.48038155 |
25 | regulation of protein activation cascade (GO:2000257) | 5.46012321 |
26 | protein carboxylation (GO:0018214) | 5.45638555 |
27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.45638555 |
28 | complement activation, alternative pathway (GO:0006957) | 5.44132155 |
29 | sulfur amino acid catabolic process (GO:0000098) | 5.37569861 |
30 | cysteine metabolic process (GO:0006534) | 5.35104289 |
31 | nitrogen cycle metabolic process (GO:0071941) | 5.27737338 |
32 | * regulation of fibrinolysis (GO:0051917) | 5.20615602 |
33 | serine family amino acid catabolic process (GO:0009071) | 5.12708817 |
34 | bile acid metabolic process (GO:0008206) | 5.09710109 |
35 | regulation of complement activation (GO:0030449) | 5.08920358 |
36 | ethanol metabolic process (GO:0006067) | 5.04262671 |
37 | reverse cholesterol transport (GO:0043691) | 5.01885536 |
38 | regulation of cholesterol esterification (GO:0010872) | 4.99188245 |
39 | aromatic amino acid family metabolic process (GO:0009072) | 4.96540457 |
40 | regulation of triglyceride catabolic process (GO:0010896) | 4.94304233 |
41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.89836305 |
42 | protein-lipid complex remodeling (GO:0034368) | 4.89836305 |
43 | macromolecular complex remodeling (GO:0034367) | 4.89836305 |
44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86393480 |
45 | tyrosine metabolic process (GO:0006570) | 4.84408025 |
46 | homocysteine metabolic process (GO:0050667) | 4.80494123 |
47 | acylglycerol homeostasis (GO:0055090) | 4.69663644 |
48 | triglyceride homeostasis (GO:0070328) | 4.69663644 |
49 | phospholipid efflux (GO:0033700) | 4.68143275 |
50 | alkaloid metabolic process (GO:0009820) | 4.67196647 |
51 | alpha-amino acid catabolic process (GO:1901606) | 4.65231522 |
52 | * negative regulation of hemostasis (GO:1900047) | 4.63680658 |
53 | * negative regulation of blood coagulation (GO:0030195) | 4.63680658 |
54 | regulation of humoral immune response (GO:0002920) | 4.60859163 |
55 | amino-acid betaine metabolic process (GO:0006577) | 4.60735182 |
56 | negative regulation of sterol transport (GO:0032372) | 4.60104389 |
57 | negative regulation of cholesterol transport (GO:0032375) | 4.60104389 |
58 | lysine catabolic process (GO:0006554) | 4.56508222 |
59 | lysine metabolic process (GO:0006553) | 4.56508222 |
60 | opsonization (GO:0008228) | 4.53269894 |
61 | plasma lipoprotein particle clearance (GO:0034381) | 4.48719403 |
62 | cellular ketone body metabolic process (GO:0046950) | 4.46757299 |
63 | * regulation of plasminogen activation (GO:0010755) | 4.46142249 |
64 | glycine metabolic process (GO:0006544) | 4.42115359 |
65 | coenzyme catabolic process (GO:0009109) | 4.39084190 |
66 | bile acid and bile salt transport (GO:0015721) | 4.38757070 |
67 | imidazole-containing compound metabolic process (GO:0052803) | 4.36779638 |
68 | indolalkylamine metabolic process (GO:0006586) | 4.35691444 |
69 | cholesterol efflux (GO:0033344) | 4.32275060 |
70 | S-adenosylmethionine metabolic process (GO:0046500) | 4.29874363 |
71 | glutamate metabolic process (GO:0006536) | 4.27816894 |
72 | cellular amino acid catabolic process (GO:0009063) | 4.27675442 |
73 | cellular biogenic amine catabolic process (GO:0042402) | 4.26095599 |
74 | amine catabolic process (GO:0009310) | 4.26095599 |
75 | cellular glucuronidation (GO:0052695) | 4.19450212 |
76 | * negative regulation of coagulation (GO:0050819) | 4.18709730 |
77 | serine family amino acid metabolic process (GO:0009069) | 4.17977964 |
78 | * negative regulation of wound healing (GO:0061045) | 4.17045492 |
79 | negative regulation of protein activation cascade (GO:2000258) | 4.16297779 |
80 | plasma lipoprotein particle assembly (GO:0034377) | 4.10106819 |
81 | benzene-containing compound metabolic process (GO:0042537) | 4.09919386 |
82 | cellular modified amino acid catabolic process (GO:0042219) | 4.08779174 |
83 | arginine metabolic process (GO:0006525) | 4.08276700 |
84 | low-density lipoprotein particle remodeling (GO:0034374) | 4.06014570 |
85 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.04947292 |
86 | aldehyde catabolic process (GO:0046185) | 4.02740859 |
87 | ethanol oxidation (GO:0006069) | 4.02256158 |
88 | serine family amino acid biosynthetic process (GO:0009070) | 4.01769122 |
89 | regulation of lipoprotein particle clearance (GO:0010984) | 3.98930808 |
90 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.95815944 |
91 | drug catabolic process (GO:0042737) | 3.90222143 |
92 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.88550221 |
93 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.88550221 |
94 | ketone body metabolic process (GO:1902224) | 3.86731260 |
95 | * positive regulation of blood coagulation (GO:0030194) | 3.84048232 |
96 | * positive regulation of hemostasis (GO:1900048) | 3.84048232 |
97 | cofactor catabolic process (GO:0051187) | 3.83983065 |
98 | complement activation, classical pathway (GO:0006958) | 3.82539628 |
99 | negative regulation of lipase activity (GO:0060192) | 3.82068347 |
100 | phospholipid homeostasis (GO:0055091) | 3.79978522 |
101 | cholesterol homeostasis (GO:0042632) | 3.79268200 |
102 | positive regulation of lipid catabolic process (GO:0050996) | 3.78921169 |
103 | complement activation (GO:0006956) | 3.78841431 |
104 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76009053 |
105 | * fibrinolysis (GO:0042730) | 3.75128777 |
106 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.74509817 |
107 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.74509817 |
108 | regulation of bile acid biosynthetic process (GO:0070857) | 3.74059081 |
109 | organic acid catabolic process (GO:0016054) | 3.73456930 |
110 | carboxylic acid catabolic process (GO:0046395) | 3.73456930 |
111 | sterol homeostasis (GO:0055092) | 3.72913178 |
112 | plasma lipoprotein particle organization (GO:0071827) | 3.72364576 |
113 | glucuronate metabolic process (GO:0019585) | 3.72053772 |
114 | uronic acid metabolic process (GO:0006063) | 3.72053772 |
115 | cytolysis (GO:0019835) | 3.71015749 |
116 | * protein activation cascade (GO:0072376) | 3.68367661 |
117 | protein-lipid complex assembly (GO:0065005) | 3.67496102 |
118 | L-serine metabolic process (GO:0006563) | 3.67216018 |
119 | acetyl-CoA metabolic process (GO:0006084) | 3.63727384 |
120 | regulation of cholesterol homeostasis (GO:2000188) | 3.63559840 |
121 | proline metabolic process (GO:0006560) | 3.63245467 |
122 | short-chain fatty acid metabolic process (GO:0046459) | 3.60185320 |
123 | * blood coagulation, intrinsic pathway (GO:0007597) | 3.59639421 |
124 | flavonoid metabolic process (GO:0009812) | 3.59476218 |
125 | regulation of apoptotic cell clearance (GO:2000425) | 3.59055708 |
126 | NAD biosynthetic process (GO:0009435) | 3.57681704 |
127 | acute-phase response (GO:0006953) | 3.57111611 |
128 | heme transport (GO:0015886) | 3.56274428 |
129 | intestinal cholesterol absorption (GO:0030299) | 3.53570049 |
130 | * positive regulation of coagulation (GO:0050820) | 3.51556334 |
131 | * acute inflammatory response (GO:0002526) | 3.50772330 |
132 | negative regulation of complement activation (GO:0045916) | 3.46295668 |
133 | arginine catabolic process (GO:0006527) | 3.43551664 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.40488303 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.20161273 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.02339560 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50035882 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.35638684 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.17206869 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.85525060 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.05590302 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.05016091 |
10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08313175 |
11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0814581 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99746656 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96990021 |
14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61470662 |
15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56002847 |
16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55973933 |
17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48366576 |
18 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40917708 |
19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.38078130 |
20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.36467708 |
21 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.36383248 |
22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34672245 |
23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21132703 |
24 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18566183 |
25 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.16794161 |
26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16614906 |
27 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.15856913 |
28 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15760693 |
29 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.10972066 |
30 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09808019 |
31 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.04209897 |
32 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02616412 |
33 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02148733 |
34 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00824725 |
35 | P68_20966046_ChIP-Seq_HELA_Human | 1.00567258 |
36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99461626 |
37 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.97358078 |
38 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96332188 |
39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92852062 |
40 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90854176 |
41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90100336 |
42 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.88385868 |
43 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.87600537 |
44 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.86452047 |
45 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.85801147 |
46 | SA1_27219007_Chip-Seq_Bcells_Human | 0.85765939 |
47 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.84994919 |
48 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84309013 |
49 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.84282539 |
50 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84018463 |
51 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83890098 |
52 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82562478 |
53 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.82475999 |
54 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.81343127 |
55 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79736874 |
56 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.79670180 |
57 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79122676 |
58 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78869936 |
59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.77858848 |
60 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.77158676 |
61 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.76916298 |
62 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76337603 |
63 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75091709 |
64 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75032764 |
65 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74909469 |
66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71717805 |
67 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71164505 |
68 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.70437725 |
69 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.70414132 |
70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70210003 |
71 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.69652548 |
72 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.69642241 |
73 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.68590380 |
74 | P300_27268052_Chip-Seq_Bcells_Human | 0.68026135 |
75 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.68024491 |
76 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.67749689 |
77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.67144367 |
78 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.66893186 |
79 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.66888670 |
80 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.66825619 |
81 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.66757927 |
82 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66356837 |
83 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66291929 |
84 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.65660559 |
85 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.65139451 |
86 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64998944 |
87 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64618464 |
88 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.64134062 |
89 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63942814 |
90 | * ERA_21632823_ChIP-Seq_H3396_Human | 0.63331135 |
91 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62930013 |
92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62930013 |
93 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.62711314 |
94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62406380 |
95 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61664774 |
96 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60700532 |
97 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60252096 |
98 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.57531528 |
99 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.56876678 |
100 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55291656 |
101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54615674 |
102 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54385888 |
103 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53100150 |
104 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52536734 |
105 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52254742 |
106 | * ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.52087600 |
107 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51727499 |
108 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51095807 |
109 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51046665 |
110 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50323092 |
111 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.49520310 |
112 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47419486 |
113 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47274845 |
114 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46939661 |
115 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.45897442 |
116 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45658854 |
117 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44945971 |
118 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44771889 |
119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44669764 |
120 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.43889309 |
121 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43202107 |
122 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42816509 |
123 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42727644 |
124 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.41611834 |
125 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.41117165 |
126 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40939505 |
127 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40874685 |
128 | GATA2_19941826_ChIP-Seq_K562_Human | 0.40788791 |
129 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40505062 |
130 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.40225458 |
131 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38544839 |
132 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38280903 |
133 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37995046 |
134 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37800163 |
135 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.36693546 |
136 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.36625335 |
137 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35956174 |
138 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35407547 |
139 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.34279681 |
140 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33780095 |
141 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.33668336 |
142 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33510980 |
143 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.33249124 |
144 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.33104196 |
145 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.32835984 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.27674185 |
2 | MP0005360_urolithiasis | 7.49248639 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.47075420 |
4 | MP0005365_abnormal_bile_salt | 6.19334039 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.13578715 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.20873130 |
7 | MP0003252_abnormal_bile_duct | 3.91840917 |
8 | MP0010329_abnormal_lipoprotein_level | 3.62848365 |
9 | MP0009840_abnormal_foam_cell | 3.36566358 |
10 | MP0005083_abnormal_biliary_tract | 3.08689875 |
11 | MP0003195_calcinosis | 2.82378085 |
12 | MP0005332_abnormal_amino_acid | 2.75457243 |
13 | MP0001666_abnormal_nutrient_absorption | 2.60122611 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.45030044 |
15 | MP0000609_abnormal_liver_physiology | 2.18448046 |
16 | MP0004019_abnormal_vitamin_homeostasis | 2.13769764 |
17 | MP0002118_abnormal_lipid_homeostasis | 2.10942843 |
18 | MP0002138_abnormal_hepatobiliary_system | 1.98424883 |
19 | MP0003868_abnormal_feces_composition | 1.95875920 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.83320220 |
21 | MP0001764_abnormal_homeostasis | 1.67910970 |
22 | MP0009697_abnormal_copulation | 1.60289571 |
23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57220297 |
24 | MP0003011_delayed_dark_adaptation | 1.46682435 |
25 | MP0005451_abnormal_body_composition | 1.44899689 |
26 | MP0003656_abnormal_erythrocyte_physiolo | 1.33880177 |
27 | MP0003186_abnormal_redox_activity | 1.26876746 |
28 | MP0009643_abnormal_urine_homeostasis | 1.21637686 |
29 | MP0000598_abnormal_liver_morphology | 1.19648637 |
30 | MP0003705_abnormal_hypodermis_morpholog | 1.15831339 |
31 | MP0005647_abnormal_sex_gland | 1.13304019 |
32 | MP0000604_amyloidosis | 1.11237123 |
33 | MP0009764_decreased_sensitivity_to | 1.06010942 |
34 | MP0002254_reproductive_system_inflammat | 1.05294465 |
35 | MP0002249_abnormal_larynx_morphology | 1.05026015 |
36 | MP0009763_increased_sensitivity_to | 1.03189958 |
37 | MP0010368_abnormal_lymphatic_system | 0.97846787 |
38 | MP0003879_abnormal_hair_cell | 0.97177288 |
39 | MP0005636_abnormal_mineral_homeostasis | 0.92400709 |
40 | MP0008469_abnormal_protein_level | 0.89972142 |
41 | MP0009642_abnormal_blood_homeostasis | 0.87558887 |
42 | MP0000566_synostosis | 0.85766584 |
43 | MP0005408_hypopigmentation | 0.84266906 |
44 | MP0002282_abnormal_trachea_morphology | 0.82514826 |
45 | MP0005670_abnormal_white_adipose | 0.82216583 |
46 | MP0006036_abnormal_mitochondrial_physio | 0.82059664 |
47 | MP0005376_homeostasis/metabolism_phenot | 0.80554564 |
48 | MP0009765_abnormal_xenobiotic_induced | 0.78715942 |
49 | MP0002078_abnormal_glucose_homeostasis | 0.77762707 |
50 | MP0005084_abnormal_gallbladder_morpholo | 0.76759954 |
51 | MP0002876_abnormal_thyroid_physiology | 0.75376189 |
52 | MP0001915_intracranial_hemorrhage | 0.73236828 |
53 | MP0005220_abnormal_exocrine_pancreas | 0.72962980 |
54 | MP0002971_abnormal_brown_adipose | 0.72371051 |
55 | MP0005187_abnormal_penis_morphology | 0.71081619 |
56 | MP0004130_abnormal_muscle_cell | 0.68676039 |
57 | MP0005334_abnormal_fat_pad | 0.68617517 |
58 | MP0003690_abnormal_glial_cell | 0.68025253 |
59 | MP0005535_abnormal_body_temperature | 0.66822855 |
60 | MP0009053_abnormal_anal_canal | 0.66601688 |
61 | MP0001661_extended_life_span | 0.66169203 |
62 | MP0005266_abnormal_metabolism | 0.64545864 |
63 | MP0003329_amyloid_beta_deposits | 0.63873825 |
64 | MP0000639_abnormal_adrenal_gland | 0.62350529 |
65 | MP0001756_abnormal_urination | 0.57952519 |
66 | MP0001348_abnormal_lacrimal_gland | 0.56873043 |
67 | MP0006035_abnormal_mitochondrial_morpho | 0.56697371 |
68 | MP0005464_abnormal_platelet_physiology | 0.55968538 |
69 | MP0005448_abnormal_energy_balance | 0.55529776 |
70 | MP0000467_abnormal_esophagus_morphology | 0.52211324 |
71 | MP0002822_catalepsy | 0.51038837 |
72 | MP0005395_other_phenotype | 0.48891980 |
73 | MP0003718_maternal_effect | 0.46897058 |
74 | MP0003638_abnormal_response/metabolism_ | 0.46415809 |
75 | MP0008873_increased_physiological_sensi | 0.45683516 |
76 | MP0008874_decreased_physiological_sensi | 0.45511782 |
77 | MP0002928_abnormal_bile_duct | 0.44895310 |
78 | MP0003436_decreased_susceptibility_to | 0.44135121 |
79 | MP0002136_abnormal_kidney_physiology | 0.44011820 |
80 | MP0009785_altered_susceptibility_to | 0.42901053 |
81 | MP0003724_increased_susceptibility_to | 0.42754347 |
82 | MP0002837_dystrophic_cardiac_calcinosis | 0.40694024 |
83 | MP0004782_abnormal_surfactant_physiolog | 0.40618783 |
84 | MP0003953_abnormal_hormone_level | 0.40148751 |
85 | MP0000678_abnormal_parathyroid_gland | 0.39445587 |
86 | MP0005248_abnormal_Harderian_gland | 0.38622437 |
87 | MP0008872_abnormal_physiological_respon | 0.38610550 |
88 | MP0004381_abnormal_hair_follicle | 0.38572217 |
89 | MP0001851_eye_inflammation | 0.38400292 |
90 | MP0005666_abnormal_adipose_tissue | 0.38105904 |
91 | MP0009672_abnormal_birth_weight | 0.37432391 |
92 | MP0000579_abnormal_nail_morphology | 0.35499214 |
93 | MP0002089_abnormal_postnatal_growth/wei | 0.34613149 |
94 | MP0004883_abnormal_blood_vessel | 0.33828869 |
95 | MP0009384_cardiac_valve_regurgitation | 0.33359475 |
96 | MP0002796_impaired_skin_barrier | 0.33154978 |
97 | MP0001243_abnormal_dermal_layer | 0.32954831 |
98 | MP0001986_abnormal_taste_sensitivity | 0.32939446 |
99 | MP0000249_abnormal_blood_vessel | 0.32861092 |
100 | MP0009115_abnormal_fat_cell | 0.32800553 |
101 | MP0005023_abnormal_wound_healing | 0.31607908 |
102 | MP0000230_abnormal_systemic_arterial | 0.31047002 |
103 | MP0002970_abnormal_white_adipose | 0.30683770 |
104 | MP0006082_CNS_inflammation | 0.30111806 |
105 | MP0002168_other_aberrant_phenotype | 0.29559095 |
106 | MP0001853_heart_inflammation | 0.29419775 |
107 | MP0001845_abnormal_inflammatory_respons | 0.28634388 |
108 | MP0001881_abnormal_mammary_gland | 0.28004006 |
109 | MP0005164_abnormal_response_to | 0.26682155 |
110 | MP0002909_abnormal_adrenal_gland | 0.25452733 |
111 | MP0002132_abnormal_respiratory_system | 0.25210406 |
112 | MP0002090_abnormal_vision | 0.24448624 |
113 | MP0002060_abnormal_skin_morphology | 0.24090035 |
114 | MP0005058_abnormal_lysosome_morphology | 0.23160460 |
115 | MP0001944_abnormal_pancreas_morphology | 0.23039656 |
116 | MP0000427_abnormal_hair_cycle | 0.22384268 |
117 | MP0002234_abnormal_pharynx_morphology | 0.21394267 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.53640887 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.45339806 |
3 | Intrahepatic cholestasis (HP:0001406) | 7.30954870 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.72304604 |
5 | Hypobetalipoproteinemia (HP:0003563) | 6.45880236 |
6 | Xanthomatosis (HP:0000991) | 6.36261209 |
7 | * Prolonged partial thromboplastin time (HP:0003645) | 6.12386718 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.65582895 |
9 | Complement deficiency (HP:0004431) | 5.48917311 |
10 | Joint hemorrhage (HP:0005261) | 4.89494022 |
11 | Hypolipoproteinemia (HP:0010981) | 4.89071943 |
12 | Hyperammonemia (HP:0001987) | 4.61536150 |
13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.57468245 |
14 | Epidermoid cyst (HP:0200040) | 4.54056970 |
15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.46947105 |
16 | Hyperglycinemia (HP:0002154) | 4.37426969 |
17 | Abnormality of methionine metabolism (HP:0010901) | 4.34538614 |
18 | Hypoalphalipoproteinemia (HP:0003233) | 4.33648055 |
19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26013601 |
20 | Ketosis (HP:0001946) | 4.24161496 |
21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.14692336 |
22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.13662596 |
23 | Fat malabsorption (HP:0002630) | 4.10285890 |
24 | Abnormality of complement system (HP:0005339) | 4.01051680 |
25 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.87010643 |
26 | Abnormality of glycine metabolism (HP:0010895) | 3.86701108 |
27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.86701108 |
28 | Hyperglycinuria (HP:0003108) | 3.86062879 |
29 | Hypoglycemic coma (HP:0001325) | 3.84049212 |
30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.67798101 |
31 | Hypercholesterolemia (HP:0003124) | 3.64449049 |
32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36731055 |
33 | Hyperbilirubinemia (HP:0002904) | 3.36130313 |
34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.31948240 |
35 | Spontaneous abortion (HP:0005268) | 3.18818696 |
36 | * Abnormality of the intrinsic pathway (HP:0010989) | 3.17333206 |
37 | Steatorrhea (HP:0002570) | 3.08680971 |
38 | Abnormality of serum amino acid levels (HP:0003112) | 3.06092522 |
39 | Delayed CNS myelination (HP:0002188) | 3.04751126 |
40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.04703267 |
41 | Hypochromic microcytic anemia (HP:0004840) | 3.04342175 |
42 | Hepatocellular carcinoma (HP:0001402) | 3.02935526 |
43 | Ketoacidosis (HP:0001993) | 2.96269259 |
44 | Myocardial infarction (HP:0001658) | 2.95958585 |
45 | Purpura (HP:0000979) | 2.82307324 |
46 | Skin nodule (HP:0200036) | 2.80770513 |
47 | Systemic lupus erythematosus (HP:0002725) | 2.79528618 |
48 | Metabolic acidosis (HP:0001942) | 2.75346668 |
49 | Abnormality of purine metabolism (HP:0004352) | 2.63549578 |
50 | Acanthocytosis (HP:0001927) | 2.62890653 |
51 | Lethargy (HP:0001254) | 2.59827079 |
52 | Neonatal hypoglycemia (HP:0001998) | 2.56105666 |
53 | Vascular calcification (HP:0004934) | 2.55316015 |
54 | Dicarboxylic aciduria (HP:0003215) | 2.55141142 |
55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.55141142 |
56 | Abnormality of the Achilles tendon (HP:0005109) | 2.53605963 |
57 | Abnormal gallbladder morphology (HP:0012437) | 2.52147978 |
58 | Glomerulonephritis (HP:0000099) | 2.50383763 |
59 | Abnormal gallbladder physiology (HP:0012438) | 2.46840189 |
60 | Cholecystitis (HP:0001082) | 2.46840189 |
61 | Hypoglycemic seizures (HP:0002173) | 2.46505233 |
62 | Cholelithiasis (HP:0001081) | 2.46429703 |
63 | Spastic diplegia (HP:0001264) | 2.45759600 |
64 | Gout (HP:0001997) | 2.44688553 |
65 | Cerebral edema (HP:0002181) | 2.43693801 |
66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.43094358 |
67 | Mitral stenosis (HP:0001718) | 2.43078018 |
68 | Amyloidosis (HP:0011034) | 2.41718083 |
69 | Neonatal onset (HP:0003623) | 2.35879143 |
70 | Irritability (HP:0000737) | 2.35727649 |
71 | Osteomalacia (HP:0002749) | 2.32314572 |
72 | Gingival bleeding (HP:0000225) | 2.31459074 |
73 | Pulmonary embolism (HP:0002204) | 2.29914448 |
74 | Reduced antithrombin III activity (HP:0001976) | 2.26216386 |
75 | Cardiovascular calcification (HP:0011915) | 2.26205286 |
76 | Esophageal varix (HP:0002040) | 2.22801743 |
77 | Malnutrition (HP:0004395) | 2.22072415 |
78 | Menorrhagia (HP:0000132) | 2.19042265 |
79 | Thrombophlebitis (HP:0004418) | 2.16039744 |
80 | Pancreatitis (HP:0001733) | 2.14442975 |
81 | Brushfield spots (HP:0001088) | 2.13880898 |
82 | Fair hair (HP:0002286) | 2.13074753 |
83 | Sensorimotor neuropathy (HP:0007141) | 2.12993675 |
84 | Enlarged kidneys (HP:0000105) | 2.12884556 |
85 | Late onset (HP:0003584) | 2.10193948 |
86 | Increased serum ferritin (HP:0003281) | 2.09594604 |
87 | Poikilocytosis (HP:0004447) | 2.08979731 |
88 | Abnormality of the gallbladder (HP:0005264) | 2.04626254 |
89 | Hemorrhage of the eye (HP:0011885) | 2.03005213 |
90 | Opisthotonus (HP:0002179) | 2.00764106 |
91 | Generalized aminoaciduria (HP:0002909) | 1.99130332 |
92 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99029405 |
93 | Bifid scrotum (HP:0000048) | 1.97461531 |
94 | Gangrene (HP:0100758) | 1.96742434 |
95 | * Vomiting (HP:0002013) | 1.96315395 |
96 | Hyperphosphaturia (HP:0003109) | 1.95877618 |
97 | Abnormality of iron homeostasis (HP:0011031) | 1.93057130 |
98 | Rickets (HP:0002748) | 1.92742192 |
99 | Atrioventricular block (HP:0001678) | 1.90818921 |
100 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89414145 |
101 | Elevated alkaline phosphatase (HP:0003155) | 1.88113998 |
102 | Abnormal cartilage morphology (HP:0002763) | 1.87345116 |
103 | Hypophosphatemic rickets (HP:0004912) | 1.85818268 |
104 | Renal cortical cysts (HP:0000803) | 1.82626754 |
105 | Hydroxyprolinuria (HP:0003080) | 1.82103152 |
106 | Abnormality of proline metabolism (HP:0010907) | 1.82103152 |
107 | Elevated hepatic transaminases (HP:0002910) | 1.81664762 |
108 | Status epilepticus (HP:0002133) | 1.79727037 |
109 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79436101 |
110 | Alkalosis (HP:0001948) | 1.79165268 |
111 | Nephritis (HP:0000123) | 1.76825939 |
112 | Impaired platelet aggregation (HP:0003540) | 1.75831659 |
113 | Abnormal platelet function (HP:0011869) | 1.75831659 |
114 | Arthropathy (HP:0003040) | 1.75808491 |
115 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.74796753 |
116 | Hyperglycemia (HP:0003074) | 1.73113445 |
117 | Reticulocytosis (HP:0001923) | 1.72108690 |
118 | Cerebral palsy (HP:0100021) | 1.68810160 |
119 | Joint swelling (HP:0001386) | 1.68776211 |
120 | Glycosuria (HP:0003076) | 1.68020956 |
121 | Abnormality of urine glucose concentration (HP:0011016) | 1.68020956 |
122 | Epistaxis (HP:0000421) | 1.64298317 |
123 | Abnormality of vitamin metabolism (HP:0100508) | 1.64123228 |
124 | Abnormal urine phosphate concentration (HP:0012599) | 1.63712689 |
125 | Increased serum pyruvate (HP:0003542) | 1.56552537 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.18945411 |
2 | FGFR4 | 4.67689615 |
3 | SIK1 | 4.50900944 |
4 | ERN1 | 4.46987323 |
5 | TAOK3 | 3.05088555 |
6 | ERBB4 | 3.03436096 |
7 | INSRR | 2.97580873 |
8 | SMG1 | 2.89275446 |
9 | MAP2K4 | 2.38397182 |
10 | PRPF4B | 2.34401687 |
11 | PKN2 | 2.20440617 |
12 | MST1R | 2.12132502 |
13 | MAPK11 | 1.96173167 |
14 | NME2 | 1.89633064 |
15 | FLT3 | 1.88526492 |
16 | ARAF | 1.86253760 |
17 | TRIB3 | 1.79385990 |
18 | TYK2 | 1.73237336 |
19 | PIK3CG | 1.66041494 |
20 | LATS1 | 1.62337144 |
21 | PDK2 | 1.56429338 |
22 | DAPK2 | 1.54832530 |
23 | EPHA2 | 1.52366649 |
24 | ABL2 | 1.51133327 |
25 | PTK6 | 1.49657761 |
26 | NEK9 | 1.41769182 |
27 | FGFR2 | 1.34043953 |
28 | KDR | 1.34037066 |
29 | FRK | 1.29889508 |
30 | EEF2K | 1.27776827 |
31 | JAK2 | 1.25375703 |
32 | TNK2 | 1.18130427 |
33 | MAP3K7 | 1.17173315 |
34 | PIM2 | 1.16426490 |
35 | GRK6 | 1.14626705 |
36 | PINK1 | 1.12009537 |
37 | MAPKAPK3 | 1.11496818 |
38 | PRKAA2 | 1.11196045 |
39 | MAP2K3 | 1.07982715 |
40 | ERBB2 | 1.07335282 |
41 | TBK1 | 1.06913369 |
42 | JAK1 | 1.02835779 |
43 | MAPK4 | 1.01276127 |
44 | MAP3K10 | 0.98982667 |
45 | STK16 | 0.98070738 |
46 | MAP3K14 | 0.94051978 |
47 | PRKCZ | 0.91912688 |
48 | NTRK3 | 0.90035904 |
49 | PIK3CA | 0.89727406 |
50 | MAP3K3 | 0.88488475 |
51 | EPHB1 | 0.88397184 |
52 | MAPK15 | 0.86595024 |
53 | MET | 0.85192112 |
54 | MAP3K11 | 0.83547141 |
55 | STK38L | 0.83062676 |
56 | MAPK12 | 0.82415745 |
57 | EPHA3 | 0.81725652 |
58 | CDK6 | 0.79962827 |
59 | PRKACG | 0.77004991 |
60 | TESK2 | 0.75947180 |
61 | TIE1 | 0.75700404 |
62 | TAOK1 | 0.75349035 |
63 | CAMK2G | 0.74552670 |
64 | DYRK1B | 0.71203956 |
65 | SCYL2 | 0.70223811 |
66 | CSK | 0.69349054 |
67 | PRKCI | 0.68095420 |
68 | GSK3A | 0.67599300 |
69 | MAP2K6 | 0.66491042 |
70 | BRAF | 0.65720122 |
71 | AKT2 | 0.64735907 |
72 | PRKAA1 | 0.64403051 |
73 | CAMKK1 | 0.64295103 |
74 | CAMK1D | 0.63921271 |
75 | SGK3 | 0.62144957 |
76 | CDK7 | 0.62044248 |
77 | RIPK1 | 0.61304464 |
78 | ILK | 0.59836934 |
79 | TGFBR2 | 0.59370621 |
80 | RPS6KB2 | 0.58614565 |
81 | IRAK3 | 0.58521579 |
82 | MAPK7 | 0.58073203 |
83 | FGFR3 | 0.57722244 |
84 | AURKA | 0.57254543 |
85 | PTK2 | 0.56897295 |
86 | IKBKE | 0.56118618 |
87 | CSF1R | 0.55266319 |
88 | MUSK | 0.54001537 |
89 | CSNK2A2 | 0.51851323 |
90 | LRRK2 | 0.51635862 |
91 | PDPK1 | 0.51192675 |
92 | PRKCQ | 0.51067227 |
93 | VRK2 | 0.50997102 |
94 | SIK2 | 0.50365157 |
95 | MAP3K2 | 0.49361347 |
96 | CSNK1G1 | 0.48436398 |
97 | PRKACA | 0.47887502 |
98 | TAOK2 | 0.47862629 |
99 | EPHA4 | 0.47661854 |
100 | CSNK2A1 | 0.45953452 |
101 | MAP3K5 | 0.45599368 |
102 | SGK2 | 0.44517731 |
103 | PKN1 | 0.44182100 |
104 | GRK1 | 0.43839653 |
105 | MAP2K1 | 0.43498211 |
106 | BRSK1 | 0.42740890 |
107 | IGF1R | 0.42240361 |
108 | PRKCG | 0.41848877 |
109 | CDK4 | 0.41674822 |
110 | MAP3K13 | 0.41586648 |
111 | DYRK2 | 0.41221106 |
112 | RET | 0.41145562 |
113 | CSNK1E | 0.39936991 |
114 | MAP3K6 | 0.39663156 |
115 | MAP3K9 | 0.39493132 |
116 | FER | 0.39439861 |
117 | ICK | 0.37308610 |
118 | CSNK1D | 0.36480988 |
119 | EIF2AK1 | 0.36001901 |
120 | MTOR | 0.35427598 |
121 | PBK | 0.35323942 |
122 | EGFR | 0.35105087 |
123 | PRKG1 | 0.34887282 |
124 | TLK1 | 0.33549993 |
125 | CAMK4 | 0.33130526 |
126 | SGK223 | 0.31471235 |
127 | SGK494 | 0.31471235 |
128 | PDK1 | 0.30868993 |
129 | CSNK1G2 | 0.28746503 |
130 | DAPK1 | 0.27369062 |
131 | CDK12 | 0.27128227 |
132 | MAP3K1 | 0.26932822 |
133 | PRKCB | 0.26385928 |
134 | CSNK1G3 | 0.26181818 |
135 | PRKCA | 0.25632260 |
136 | RPS6KA3 | 0.25566603 |
137 | LATS2 | 0.25396951 |
138 | IRAK1 | 0.24096144 |
139 | CHUK | 0.23470628 |
140 | IRAK4 | 0.22852672 |
141 | MAP2K2 | 0.22591453 |
142 | BMX | 0.21351270 |
143 | IRAK2 | 0.21263305 |
144 | ABL1 | 0.21102687 |
145 | PAK3 | 0.20896396 |
146 | MAPK3 | 0.18180824 |
147 | CAMK1G | 0.17700378 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.55764930 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.65791647 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.45277045 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31435517 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.12205347 |
6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.78169279 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67761008 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67702937 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63033619 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56429329 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47978697 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35769706 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.21712592 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13321282 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10363027 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.06992652 |
17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93050402 |
18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90977316 |
19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89998895 |
20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89464893 |
21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89420179 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87652098 |
23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80445440 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79632993 |
25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.76263707 |
26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75545307 |
27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.74365643 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69039241 |
29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67978493 |
30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63477197 |
31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.60070523 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59142940 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57031170 |
34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.53277333 |
35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51545219 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.48528891 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43941906 |
38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35385295 |
39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34900831 |
40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33505933 |
41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32995672 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26661242 |
43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22416481 |
44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21346465 |
45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20797564 |
46 | ABC transporters_Homo sapiens_hsa02010 | 1.19131118 |
47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17810627 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12894798 |
49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05201720 |
50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00723978 |
51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99170020 |
52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98234155 |
53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96974822 |
54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96367733 |
55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95874293 |
56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87550891 |
57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86204349 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83623470 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80118414 |
60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76599511 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70299888 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66512146 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64637666 |
64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59216462 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52203186 |
66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46818256 |
67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45946869 |
68 | Prion diseases_Homo sapiens_hsa05020 | 0.38518875 |
69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38103813 |
70 | Pertussis_Homo sapiens_hsa05133 | 0.33744131 |
71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25650232 |
72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25382481 |
73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24679650 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.23182113 |
75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22233658 |
76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22147020 |
77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19501213 |
78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16501161 |
79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10177206 |
80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02097154 |
81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.00438042 |
82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2432976 |
83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2414671 |
84 | Bladder cancer_Homo sapiens_hsa05219 | -0.2414548 |
85 | Amoebiasis_Homo sapiens_hsa05146 | -0.2385627 |
86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2374276 |
87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2287395 |
88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1981498 |
89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1912045 |
90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1903552 |
91 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1885830 |
92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1738271 |
93 | Hepatitis C_Homo sapiens_hsa05160 | -0.1734259 |
94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1689143 |
95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1578144 |
96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1555620 |
97 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1412796 |
98 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1408360 |
99 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1323892 |
100 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1268117 |
101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1225561 |
102 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1173581 |
103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1020396 |
104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0881266 |
105 | Mineral absorption_Homo sapiens_hsa04978 | -0.0874745 |
106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0736310 |
107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0716514 |
108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0400449 |